Do you want to read an article? Please log in or register.
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
Cough
RECOMMENDED
Related content
Pulmonary Hypertension
Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Ann Am Thorac Soc
McCarthy BE, Feng R, Bernardo R, Shlobin OA, De Marco T, Wichman T, Presberg KW, Ravichandran A, Horn EM, Elwing JM, George MP, Runo JR, Safdar Z, Ventetuolo CE, Al-Naamani N, PHAR investigators
doi: 10.1093/annalsats/aaoag141
Pulmonary Hypertension
Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study
Lancet
McLaughlin VV, Solum D, Lachant D, Ataya A, Barberà JA, Meyer GB, Chang SA, Channick R, Church C, Feenstra J, Gaine S, Giannakoulas G, Jerjes-Sanchez C, Khanna D, Kim NH, Oudiz R, Preston IR, Sood N, Torres F, Vachiery JL, Pulido T, Cella D, Deng C, Escudero M, Lacasse V, Peterson L, Benza R, Humbert M, ADVANCE OUTCOMES Investigators
doi: 10.1016/S0140-6736(26)01011-1
RECOMMENDED
Pulmonary Hypertension
Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
Chest
Szwed P, Kurzyna P, Banaszkiewicz-Cyganik M, Kędzierski P, Łomiak M, Wolański R, Wasilewski M, Florczyk M, Piłka M, Torbicki A, Kurzyna M, Darocha S
doi: 10.1016/j.chest.2025.10.017
RECOMMENDED
Pulmonary Hypertension
Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
J Clin Med
Hirono K, Uchida K, Ishii T, Ishida H, Takatsuki S, Fukushima H, Inai K, Hosokawa S, Ishizaki R, Sawada H, Sumitomo NF, Chida-Nagai A, Ishikawa Y, Motoki H, Yao A, Kogaki S, Yamagishi H, Doi S
doi: 10.3390/jcm15031087
COMMENTED
COPD
Summary of Research: Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trials (the ENHANCE Trials)
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Adv Ther
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Rickard K, O'Donovan K, Sciurba F
doi: 10.1007/s12325-026-03514-6
Pulmonary Hypertension
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period
Adv Ther
Ford HJ, Chin KM, Fan F, Friberg M, Grünig E, Hauser JA, Pannaux M, Rofael H, Jansa P
doi: 10.1007/s12325-026-03525-3
Interstitial Lung DiseasePulmonary Fibrosis
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Am J Respir Crit Care Med
Maher TM, Hamblin MJ, Choi WI, Case AH, Tomos IP, Tzouvelekis AE, Shore JE, Bergna MA, Golod D, Elenko E, Zhang Y, Graham CS, Song JW, Kulkarni T, ELEVATE IPF Investigators (listed in Supplementary Appendix)
doi: 10.1093/ajrccm/aamag155
ARDSPneumonia
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
Lancet Respir Med
Leslie K, Darvall JN, Chan MTV, Peyton PJ, Myles PS, Corcoran TB, Short TG, Olesnicky BL, Webb AR, Devlin N, Tran-Duy A, Maxwell-Wright H, Schultz-Ferguson C, Fitzpatrick P, Sidiropoulos S, Braat S, Story DA, SNaPP Study Investigators and the Australian and New Zealand College of Anaesthetists Clinical Trials Network
doi: 10.1016/S2213-2600(26)00158-X
COPD
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
Lancet
Papi A, Greening NJ, Bhatt SP, Roche N, Celli B, Wedzicha JA, Agustí À, Tal-Singer R, Han MK, Janssens W, Hanania NA, Nair P, Bremner P, Porpodis K, Shibata Y, Korn S, Yang T, Gordon O, Saenz R, Ng J, Cheung DS, Devine J, Grimbaldeston MA, Zhang W, Yang X, Mohan D, Vogelmeier CF, Brightling CE, ALIENTO and ARNASA investigators
doi: 10.1016/S0140-6736(26)00637-9